US OptionsDetailed Quotes

CRL250516P135000

Watchlist

21.00
0.000.00%

15min DelayClose May 2 15:59 ET

0.00High0.00Low

Charles River Stock Discussion

韭菜变主力

Apr 11 08:07

$Charles River (CRL.US)$ Tragedy.

韭菜变主力

Jan 18 12:05

$Charles River (CRL.US)$ It’s cheap, but no sizable upside without material improvement of the earnings. 140s might be in the cards. Go against the trend is a dangerous thing. Those sitting on a loss have to cut loss given the extreme resistance above. Only improvement of the earnings can save this stock. They also seem to be losing some clients to competitors.

韭菜变主力

Dec 30, 2024 15:18

$Charles River (CRL.US)$ In this almost everything rally market with stocks doubling easily, biomedical research companies have found growth is extremely hard to come by, and P/E has been stuck going nowhere.

Moomoo AI

Feb 29, 2024 15:09

The CEOs of both Wheeler Bio and Charles River express optimism about the partnership, believing that the integration of discovery CRO and CDMO workflows will speed up the path to first-in-human trials and bring new treatments to patients faster.

Press Release: Wheeler Bio Seals Agreement With Charles River to Offer Portable CMC(R) to Discovery Clients to Accelerate Their Journey to First-in-Human Use

Moomoo AI

Feb 26, 2024 18:44

Insider's recent share sale, even below current price, suggests satisfaction with lower valuation. Despite high insider ownership, this selling hints at caution. The company also has 1 warning sign worth noting before buying shares.

Have Charles River Laboratories International Insiders Been Selling Stock?

Moomoo AI

Feb 16, 2024 23:18

EPS growth outshines the yearly share price gain of 12%, indicating market caution towards the stock. Despite sell-off, long term shareholders gained 12% annually over five years, suggesting the sell-off might be a growth opportunity.

Charles River Laboratories International (NYSE:CRL) Stock Performs Better Than Its Underlying Earnings Growth Over Last Five Years

Moomoo AI

Jan 17, 2024 20:06

Charles River Laboratories International's high P/E ratio is concerning due to its lower than expected growth. Investors seem more bullish than analysts, but current prices may not be sustainable without significant improvement.

Getting In Cheap On Charles River Laboratories International, Inc. (NYSE:CRL) Is Unlikely

Moomoo AI

Nov 17, 2023 18:30

The recent and long-term insider transactions demonstrate a positive outlook about the company. The significant insider ownership of the company also indicates well-aligned incentives between the management and shareholders. Charles River Laboratories International may potentially be a promising investment.

James Foster Bought 2.3% More Shares In Charles River Laboratories International

GAME_DAY

Jun 13, 2023 05:40

TOP WATCH AH + 6/13 ⚡️⚡️

$Auddia (AUUD.US)$ $Charles River (CRL.US)$ $Devon Energy (DVN.US)$ $Eastside Distilling (EAST.US)$ $Finch Therapeutics (FNCH.US)$ $Forza X1(Delisted) (FRZA.US)$ $iBio Inc (IBIO.US)$ $Disc Medicine (IRON.US)$ $Leju Holdings (LEJU.US)$ $Lumen Technologies (LUMN.US)$ $MediaCo (MDIA.US)$ $The OLB Group (OLB.US)$ $Oracle (ORCL.US)$ $Rockwell Medical (RMTI.US)$ $Target (TGT.US)$

Mooers Radar

Jan 12, 2023 17:39

Columns US Top Gap Ups and Downs on 1/11: SONY, TOLL, FERG, NVO and More

Here are the top gap ups and downs for the stocks with a market cap above $5 billion after the previous market closed (gaps range from large to small):
Gap Ups
1. $Topbuild (BLD.US)$ - up 2.7%
2. $Atlassian (TEAM.US)$ - up 2.4%
3. $Pool Corp (POOL.US)$ - up 2%
4. $Sony (SONY.US)$ - up 1.9%
5. $Toll Brothers (TOL.US)$ - up 1.8%
6. $Charles River (CRL.US)$ - up 1.4%
7. $Gaming and Leisure Properties Inc (GLPI.US)$ - up 1.4%
8. $WPP PLC (WPP.US)$ - up 1.3%...

+15

No comment yet